Apigenin exerts chemopreventive effects on lung injury induced by SiO2 nanoparticles through the activation of Nrf2

Authors:

Abstract
Apigenin (APG) is a flavonoid widely distributed in fruits, vegetables, and herbs, with comprehensive pharmacological effects. In this paper, we report that APG can elicit a protective effect, which is comparable to those induced by gymnoside II/n-BuOH extracts of Bletilla striata, on SiO2-induced lung injury in vitro and in vivo. In vitro experiments showed that APG (25 μM) could restore the SiO2-decreased A549 cell viability and lower the apoptotic rate and the production of intracellular reactive oxygen species (ROS) in A549 cells treated with nm SiO2. Western blot results showed that APG (25 μM) could increase the level of Nuclear factor E2-related factor 2 (Nrf2) and its downstream proteins. In vivo experiments showed that APG (20 mg/kg) could potently alleviate the SiO2-elicited lung injury by enhancing the Nrf2 expression and thereby suppressing Bax/Bcl-2 pathway. The present study suggests that APG can significantly alleviate the SiO2-induced lung injury both in vitro and in vivo through, at least partially, activating Nrf2 expression. Graphic abstract
Funding Information
  • National Natural Science Foundation of China (U1903122, 81872768)
  • Liaoning Revitalization Talents Program (XLYC1807118)
  • shenyang young scientific and technological innovators program (RC200408)
  • the fund of state key laboratory of phytochemistry and plant resources in west china (P2020-KF01)
  • State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Education (CMEMR2021-B01)
  • Educational Committee Foundation of Liaoning Province (2020LJC09)
  • Doctoral Scientific Research Foundation of Liaoning Province (2020-BS-129)
  • special fund of research institute of drug regulatory science research shenyang pharmaceutical university (2021jgkx010)

This publication has 40 references indexed in Scilit: